- Report
- February 2021
- 420 Pages
United States
From €2184EUR$2,400USD£1,873GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1138EUR$1,250USD£975GBP
- Report
- May 2022
- 83 Pages
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Amisulpride is a drug used to treat mental disorders, such as schizophrenia, bipolar disorder, and major depressive disorder. It is a selective dopamine antagonist, meaning it blocks the action of dopamine in the brain. It is available in both oral and injectable forms. Amisulpride is generally well-tolerated and has fewer side effects than other antipsychotic medications. It is also used off-label to treat anxiety and other mental health conditions.
Amisulpride is marketed by several pharmaceutical companies, including Sun Pharmaceuticals, Intas Pharmaceuticals, and Lupin Pharmaceuticals. Other companies that produce and market the drug include Mylan, Dr. Reddy's Laboratories, and Torrent Pharmaceuticals. Show Less Read more